Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
31 locations incl. Tuscon
Sponsor: Dendreon
Sex: Male·Age: 18+
Code: NCT06134232·Phase 2·Recruiting